Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 554.52M
December 31, 2024 781.32M
December 31, 2023 750.09M
December 31, 2022 998.92M
Date Value
December 31, 2021 958.07M
December 31, 2020 678.06M
December 31, 2019 355.82M
December 31, 2018 421.50M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
AbbVie, Inc. 5.257B
TG Therapeutics, Inc. 141.97M
Karyopharm Therapeutics, Inc. 63.74M
Krystal Biotech, Inc. 827.79M
Akebia Therapeutics, Inc. 186.54M